Stockscreener 앱 받기
16.31
0.85%
-0.19
Anika Therapeutics Inc 주식(ANIK)의 최신 뉴스
Facial Aesthetics Market Generated Opportunities, Future - openPR
Orthopedic Digit Implants Market: Share, Revenue Insights, - openPR
Barclays PLC Purchases 13,054 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Viscosupplementation Market Generated Opportunities, Future - openPR
(ANIK) Proactive Strategies - Stock Traders Daily
Anika Therapeutics stock hits 52-week low at $15.8 By Investing.com - Investing.com Australia
Anika Therapeutics stock hits 52-week low at $15.8 - Investing.com India
Jane Street Group LLC Increases Stake in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by Geode Capital Management LLC - Defense World
Barclays PLC Buys 13,054 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
We Think Anika Therapeutics (NASDAQ:ANIK) Can Easily Afford To Drive Business Growth - Yahoo Finance
State Street Corp Sells 7,667 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Bought by HighTower Advisors LLC - Defense World
Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Anika Therapeutics to Present at JPM Healthcare Conference 2025: Joint Preservation Leader Takes Stage - StockTitan
(ANIK) On The My Stocks Page - Stock Traders Daily
Fmr LLC Acquires 4,996 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Improved Revenues Required Before Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Find Their Feet - Simply Wall St
Anika Therapeutics stock hits 52-week low at $15.99 - Investing.com
Verition Fund Management LLC Sells 1,763 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Short Interest Update - MarketBeat
Knee Osteoarthritis Market Projected CAGR 12.5% Dynamics - openPR
Joint Pain Injection Market Expected to Reach Prominent Growth - openPR
ANIK (Anika Therapeutics) Net Issuance of Preferred Stock : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
Osteoarthritis Therapeutics Market Size to Reach USD 24.34 Bn by 2034 - GlobeNewswire Inc.
Anika To Participate in December 2024 Investor Conferences - The Manila Times
Anika Therapeutics to Present at Three Major Healthcare Investor Conferences in December | ANIK Stock News - StockTitan
Orthopedic Regenerative Surgical Products Market to Witness - openPR
Joint Pain Injection Market Size, Share, Trends, - openPR
New Strong Sell Stocks for November 11th - Yahoo Canada Finance
Orthobiologics Market Size, Growth, Opportunities 2024-2032 | - openPR
Anika Therapeutics Navigates Geopolitical Risks Amid Global Conflicts - TipRanks
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by Capital Management Corp VA - MarketBeat
Anika Therapeutics Announces Third Quarter Financial ResultsOn October 31, 2024, Anika Therapeutics, Inc. released a press statement unveiling its financial outcomes for the third quarter concluding on September 30, 2024. As per the report - Defense World
Viscosupplementation Market Report Analysis, Growth - openPR
Anika Therapeutics (NASDAQ:ANIK) Downgraded to Hold Rating by StockNews.com - MarketBeat
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2024 Earnings Call Transcript - Insider Monkey
Barrington Research Cuts Anika Therapeutics (NASDAQ:ANIK) Price Target to $25.00 - Defense World
Earnings call: Anika Therapeutics Focuses on HA Products Amid Restructuring By Investing.com - Investing.com South Africa
Earnings call: Anika Therapeutics Focuses on HA Products Amid Restructuring - Investing.com
Anika Therapeutics Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St
Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates - MSN
Anika Therapeutics (NASDAQ:ANIK) Given New $25.00 Price Target at Barrington Research - MarketBeat
Anika Therapeutics (NASDAQ:ANIK shareholders incur further losses as stock declines 30% this week, taking five-year losses to 72% - Simply Wall St
Anika: Q3 Earnings Snapshot - New Haven Register
Anika Therapeutics Inc (ANIK) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... - Yahoo Finance UK
Anika Therapeutics Inc (ANIK) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline - GuruFocus.com
Anika Therapeutics divests Arthrosurface, eyes Parcus sale - Investing.com India
Anika Therapeutics Focuses on Core Growth Amid Restructuring - TipRanks
Anika Reports Third Quarter 2024 Financial Results - GlobeNewswire
Anika Therapeutics divests Arthrosurface, eyes Parcus sale By Investing.com - Investing.com Canada
Anika Therapeutics stock hits 52-week low at $18.67 - Investing.com
0.56%
0.71%
자본화:
|
볼륨(24시간):